Clearside Biomedical Inc
NASDAQ:CLSD

Watchlist Manager
Clearside Biomedical Inc Logo
Clearside Biomedical Inc
NASDAQ:CLSD
Watchlist
Price: 1.08 USD 5.88% Market Closed
Market Cap: 80.7m USD
Have any thoughts about
Clearside Biomedical Inc?
Write Note

Intrinsic Value

CLSD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CLSD stock under the Base Case scenario is 0.63 USD. Compared to the current market price of 1.08 USD, Clearside Biomedical Inc is Overvalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CLSD Intrinsic Value
0.63 USD
Overvaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Clearside Biomedical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CLSD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CLSD?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Clearside Biomedical Inc

Provide an overview of the primary business activities
of Clearside Biomedical Inc.

What unique competitive advantages
does Clearside Biomedical Inc hold over its rivals?

What risks and challenges
does Clearside Biomedical Inc face in the near future?

Has there been any significant insider trading activity
in Clearside Biomedical Inc recently?

Summarize the latest earnings call
of Clearside Biomedical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Clearside Biomedical Inc.

Provide P/S
for Clearside Biomedical Inc.

Provide P/E
for Clearside Biomedical Inc.

Provide P/OCF
for Clearside Biomedical Inc.

Provide P/FCFE
for Clearside Biomedical Inc.

Provide P/B
for Clearside Biomedical Inc.

Provide EV/S
for Clearside Biomedical Inc.

Provide EV/GP
for Clearside Biomedical Inc.

Provide EV/EBITDA
for Clearside Biomedical Inc.

Provide EV/EBIT
for Clearside Biomedical Inc.

Provide EV/OCF
for Clearside Biomedical Inc.

Provide EV/FCFF
for Clearside Biomedical Inc.

Provide EV/IC
for Clearside Biomedical Inc.

Show me price targets
for Clearside Biomedical Inc made by professional analysts.

What are the Revenue projections
for Clearside Biomedical Inc?

How accurate were the past Revenue estimates
for Clearside Biomedical Inc?

What are the Net Income projections
for Clearside Biomedical Inc?

How accurate were the past Net Income estimates
for Clearside Biomedical Inc?

What are the EPS projections
for Clearside Biomedical Inc?

How accurate were the past EPS estimates
for Clearside Biomedical Inc?

What are the EBIT projections
for Clearside Biomedical Inc?

How accurate were the past EBIT estimates
for Clearside Biomedical Inc?

Compare the revenue forecasts
for Clearside Biomedical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Clearside Biomedical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Clearside Biomedical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Clearside Biomedical Inc compared to its peers.

Compare the P/E ratios
of Clearside Biomedical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Clearside Biomedical Inc with its peers.

Analyze the financial leverage
of Clearside Biomedical Inc compared to its main competitors.

Show all profitability ratios
for Clearside Biomedical Inc.

Provide ROE
for Clearside Biomedical Inc.

Provide ROA
for Clearside Biomedical Inc.

Provide ROIC
for Clearside Biomedical Inc.

Provide ROCE
for Clearside Biomedical Inc.

Provide Gross Margin
for Clearside Biomedical Inc.

Provide Operating Margin
for Clearside Biomedical Inc.

Provide Net Margin
for Clearside Biomedical Inc.

Provide FCF Margin
for Clearside Biomedical Inc.

Show all solvency ratios
for Clearside Biomedical Inc.

Provide D/E Ratio
for Clearside Biomedical Inc.

Provide D/A Ratio
for Clearside Biomedical Inc.

Provide Interest Coverage Ratio
for Clearside Biomedical Inc.

Provide Altman Z-Score Ratio
for Clearside Biomedical Inc.

Provide Quick Ratio
for Clearside Biomedical Inc.

Provide Current Ratio
for Clearside Biomedical Inc.

Provide Cash Ratio
for Clearside Biomedical Inc.

What is the historical Revenue growth
over the last 5 years for Clearside Biomedical Inc?

What is the historical Net Income growth
over the last 5 years for Clearside Biomedical Inc?

What is the current Free Cash Flow
of Clearside Biomedical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Clearside Biomedical Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Clearside Biomedical Inc

Current Assets 25.1m
Cash & Short-Term Investments 23.6m
Receivables 788k
Other Current Assets 734k
Non-Current Assets 4m
PP&E 4m
Other Non-Current Assets 30k
Current Liabilities 5.6m
Accounts Payable 2.4m
Accrued Liabilities 3.2m
Non-Current Liabilities 58.4m
Other Non-Current Liabilities 58.4m
Efficiency

Earnings Waterfall
Clearside Biomedical Inc

Revenue
7.7m USD
Cost of Revenue
-230k USD
Gross Profit
7.5m USD
Operating Expenses
-32.1m USD
Operating Income
-24.6m USD
Other Expenses
-7.2m USD
Net Income
-31.9m USD

Free Cash Flow Analysis
Clearside Biomedical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CLSD Profitability Score
Profitability Due Diligence

Clearside Biomedical Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
37/100
Profitability
Score

Clearside Biomedical Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

CLSD Solvency Score
Solvency Due Diligence

Clearside Biomedical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
50/100
Solvency
Score

Clearside Biomedical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CLSD Price Targets Summary
Clearside Biomedical Inc

Wall Street analysts forecast CLSD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLSD is 6.12 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.05 USD
368% Upside
Average
Price Target
6.12 USD
467% Upside
Highest
Price Target
8.4 USD
678% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CLSD?

Click here to dive deeper.

Dividends

Clearside Biomedical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CLSD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CLSD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Clearside Biomedical Inc Logo
Clearside Biomedical Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

80.7m USD

Dividend Yield

0%

Description

Clearside Biomedical, Inc. is a biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. The company is headquartered in Alpharetta, Georgia and currently employs 34 full-time employees. The company went IPO on 2016-06-02. The firm is focused on developing and delivering therapies to the back of the eye diseases through the suprachoroidal space (SCS). Its SCS injection platform utilizing its SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted delivery of a variety of therapies to the macula, retina or choroid to preserve and improve vision in patients with sight-threatening eye diseases. The company is focused on developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector, and it also partners with companies developing other ophthalmic therapeutics to be administered using its SCS injection platform. Its lead product candidate, XIPERE, is a preservative-free suspension of the corticosteroid triamcinolone acetonide (TA), formulated for administration through suprachoroidal injection. Its pipeline includes CLS-AX, CLS-301 and Gene Therapy.

Contact

GEORGIA
Alpharetta
900 N Point Pkwy Ste 200
+16782703631.0
clearsidebio.com

IPO

2016-06-02

Employees

34

Officers

President, CEO & Director
Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Chief Financial Officer
Mr. Charles A. Deignan
Head of Investor Relations
Ms. Jenny R. Kobin
Senior Vice President of Corporate Development & Alliance Management
Mr. Rick McElheny
Senior Vice President of Engineering & Manufacturing
Mr. Rafael V. Andino
Chief Clinical Officer
Ms. Susan L. Coultas Ph.D.
Show More
Chief Medical Officer
Dr. Ngai Hang Chong FRCOphth, FRCS, M.B.A., M.D.
Secretary
Mr. Leslie B. Zacks
Show Less

See Also

Discover More
What is the Intrinsic Value of one CLSD stock?

The intrinsic value of one CLSD stock under the Base Case scenario is 0.63 USD.

Is CLSD stock undervalued or overvalued?

Compared to the current market price of 1.08 USD, Clearside Biomedical Inc is Overvalued by 41%.

Back to Top